Craig Millian - Net Worth and Insider Trading
Craig Millian Net Worth
The estimated net worth of Craig Millian is at least $43,250 dollars as of 2024-11-13. Craig Millian is the Director, Senior Officer of HLS Therapeutics Inc and owns about 12,500 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $43,250. Details can be seen in Craig Millian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig Millian has not made any transactions after 2024-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig Millian
Craig Millian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig Millian owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .
Click here to see the complete history of Craig Millian’s form 4 insider trades.
Insider Ownership Summary of Craig Millian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2024-05-15 | Director & Senior Officer |
Craig Millian Latest Holdings Summary
Craig Millian currently owns a total of 1 stock. Craig Millian owns 12,500 shares of HLS Therapeutics Inc (TSX:HLS) as of May 15, 2024, with a value of $43,250.
Latest Holdings of Craig Millian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2024-05-15 | 12,500 | 3.46 | 43,250 |
Holding Weightings of Craig Millian
Craig Millian Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig Millian has made a total of 4 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in HLS Therapeutics Inc is the acquisition of 2,500 shares on May 15, 2024, which cost Craig Millian around $9,814.
Insider Trading History of Craig Millian
- 1
Craig Millian Trading Performance
GuruFocus tracks the stock performance after each of Craig Millian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig Millian is 3.39%. GuruFocus also compares Craig Millian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig Millian within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig Millian's insider trading performs compared to the benchmark.
Performance of Craig Millian
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.1 | | | | | |
| Relative Return to S&P 500(%) | 12.3 | | | | | |
Craig Millian Ownership Network
Ownership Network List of Craig Millian
Ownership Network Relation of Craig Millian
Craig Millian Owned Company Details
What does HLS Therapeutics Inc do?
Who are the key executives at HLS Therapeutics Inc?
Craig Millian is the Director & Senior Officer of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Senior Officer Brian Thomas Walsh , 10% Security Holder Polar Asset Management Partners Inc. , and Director & Senior Officer John Gordon Hanna .
HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary
Over the past 18 months, Craig Millian made 4 insider transaction in HLS Therapeutics Inc (TSX:HLS) with a net purchase of 12,500. Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. , and a net purchase of 1,200 shares made by Brian Thomas Walsh .
In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.
HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
HLS Therapeutics Inc Insider Transactions
Craig Millian Mailing Address
Above is the net worth, insider trading, and ownership report for Craig Millian. Currently GuruFocus does not have mailing address information for Craig Millian.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
